z-logo
Premium
Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature
Author(s) -
MagdalenoTapial Jorge,
ValenzuelaOñate Cristian,
GarcíaLegazMartínez Marta,
MartínezDomenech Álvaro,
PérezFerriols Amparo
Publication year - 2020
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.13208
Subject(s) - dupilumab , alopecia areata , atopic dermatitis , medicine , dermatology
Dupilumab, a biologic drug approved for the treatment of moderate‐to‐severe atopic dermatitis, has been associated with resolution or improvement in pre‐existing alopecia areata. We report a case of significant improvement of AA after Dupilumab‐onset treatment for atopic dermatitis and review the literature.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here